These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2785819)

  • 1. Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients.
    Hedner J; Hedner T; Lundell KH; Bissette G; O'Connor L; Nemeroff CB
    Biol Neonate; 1989; 55(4-5):260-7. PubMed ID: 2785819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin-like immunoreactivity (NTLI) concentration in the cerebrospinal fluid of children and its alteration in a febrile aseptic meningitis.
    Muraki K; Nishi Y; Okahata H; Arai M; Yamada H; Fujita S; Miyachi Y; Ueda K; Yamawaki S; Yajima H
    Life Sci; 1987 Apr; 40(14):1365-70. PubMed ID: 3561155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.
    Suda T; Tozawa F; Mouri T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):225-6. PubMed ID: 6602142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus.
    Ceccatelli S; Eriksson M; Hökfelt T
    Neuroendocrinology; 1989 Mar; 49(3):309-23. PubMed ID: 2469987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations.
    Coplan JD; Smith EL; Trost RC; Scharf BA; Altemus M; Bjornson L; Owens MJ; Gorman JM; Nemeroff CB; Rosenblum LA
    Psychiatry Res; 2000 Aug; 95(2):93-102. PubMed ID: 10963795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corticotropin-releasing factor concentrations in cerebrospinal fluid and its diurnal rhythm in patients with Cushing's disease].
    Yokoe T; Kuwayama A; Ichihara K; Yamamoto N; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):964-70. PubMed ID: 6334621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of biogenic amines and corticotropin-releasing factor in adolescent non-human primates as a function of the timing of adverse early rearing.
    Mathew SJ; Coplan JD; Smith EL; Scharf BA; Owens MJ; Nemeroff CB; Mann JJ; Gorman JM; Rosenblum LA
    Stress; 2002 Sep; 5(3):185-93. PubMed ID: 12186681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N; Suda T; Tozawa F; Demura H; Shizume K; Mouri T
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1305-7. PubMed ID: 6605358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF neuropeptide Y in alcoholics and normal controls.
    Roy A; Berrettini W; DeJong J; Adinoff B; Ravitz B; Linnoila M
    Psychiatry Res; 1990 Sep; 33(3):215-9. PubMed ID: 1978753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronized maternal-infant elevations of primate CSF CRF concentrations in response to variable foraging demand.
    Coplan JD; Altemus M; Mathew SJ; Smith EL; Sharf B; Coplan PM; Kral JG; Gorman JM; Owens MJ; Nemeroff CB; Rosenblum LA
    CNS Spectr; 2005 Jul; 10(7):530-6. PubMed ID: 16155510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable foraging demand rearing: sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates.
    Coplan JD; Smith EL; Altemus M; Scharf BA; Owens MJ; Nemeroff CB; Gorman JM; Rosenblum LA
    Biol Psychiatry; 2001 Aug; 50(3):200-4. PubMed ID: 11513819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF neuropeptides in euthymic bipolar patients and controls.
    Berrettini WH; Nurnberger JI; Zerbe RL; Gold PW; Chrousos GP; Tomai T
    Br J Psychiatry; 1987 Feb; 150():208-12. PubMed ID: 2888503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects.
    Fossey MD; Lydiard RB; Ballenger JC; Laraia MT; Bissette G; Nemeroff CB
    Biol Psychiatry; 1996 Apr; 39(8):703-7. PubMed ID: 8731457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.
    McLean SA; Williams DA; Stein PK; Harris RE; Lyden AK; Whalen G; Park KM; Liberzon I; Sen A; Gracely RH; Baraniuk JN; Clauw DJ
    Neuropsychopharmacology; 2006 Dec; 31(12):2776-82. PubMed ID: 16936702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
    Neuropsychopharmacology; 2003 Mar; 28(3):569-76. PubMed ID: 12629539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
    Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M
    J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.
    Carpenter LL; Tyrka AR; McDougle CJ; Malison RT; Owens MJ; Nemeroff CB; Price LH
    Neuropsychopharmacology; 2004 Apr; 29(4):777-84. PubMed ID: 14702025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced lumbar cerebrospinal fluid corticotropin releasing factor (CRF) levels in amyotrophic lateral sclerosis.
    Klimek A; Cieślak D; Szulc-Kuberska J; Stepien H
    Acta Neurol Scand; 1986 Jul; 74(1):72-4. PubMed ID: 3490112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.